Invention Grant
- Patent Title: Azetidine compounds as orexin receptor antagonists
- Patent Title (中): 氮杂环丁烷化合物作为食欲素受体拮抗剂
-
Application No.: US12377349Application Date: 2007-08-15
-
Publication No.: US07994336B2Publication Date: 2011-08-09
- Inventor: Hamed Aissaoui , Christoph Boss , Markus Gude , Ralf Koberstein , Thierry Sifferlen
- Applicant: Hamed Aissaoui , Christoph Boss , Markus Gude , Ralf Koberstein , Thierry Sifferlen
- Applicant Address: CH Allschwil
- Assignee: Actelion Pharmaceuticals Ltd.
- Current Assignee: Actelion Pharmaceuticals Ltd.
- Current Assignee Address: CH Allschwil
- Agency: Hoxie & Assoicates LLC
- Agent Brittany La
- Priority: WOPCT/IB2006/052814 20060815
- International Application: PCT/IB2007/053244 WO 20070815
- International Announcement: WO2008/020405 WO 20080221
- Main IPC: C07D513/04
- IPC: C07D513/04 ; C07D277/00 ; C07D205/00 ; A61K31/427 ; A61K31/431 ; A61K31/337
Abstract:
The invention relates to novel azetidine compounds of formula (I), wherein R1, R2, and X are as described in the description and their use as orexin receptor antagonists.
Public/Granted literature
- US20100222600A1 AZETIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS Public/Granted day:2010-09-02
Information query
